181 related articles for article (PubMed ID: 34456573)
1. Tetrandrine Inhibits Epithelial-Mesenchymal Transition in IL-6-Induced HCT116 Human Colorectal Cancer Cells.
Tsai SC; Wu WC; Yang JS
Onco Targets Ther; 2021; 14():4523-4536. PubMed ID: 34456573
[TBL] [Abstract][Full Text] [Related]
2. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
4. Tetrandrine reverses epithelial-mesenchymal transition in bladder cancer by downregulating Gli-1.
Zhang Y; Liu W; He W; Zhang Y; Deng X; Ma Y; Zeng J; Kou B
Int J Oncol; 2016 May; 48(5):2035-42. PubMed ID: 26983576
[TBL] [Abstract][Full Text] [Related]
5. TAGLN2 promotes the proliferation, invasion, migration and epithelial-mesenchymal transition of colorectal cancer cells by activating STAT3 signaling through ANXA2.
Zhao Z; Lu L; Li W
Oncol Lett; 2021 Oct; 22(4):737. PubMed ID: 34466149
[TBL] [Abstract][Full Text] [Related]
6. Herbal prescription, Danggui-Sayuk-Ga-Osuyu-Senggang-Tang, inhibits TNF-α-induced epithelial-mesenchymal transition in HCT116 colorectal cancer cells.
Lee K; Cho SG; Choi YK; Choi YJ; Lee GR; Jeon CY; Ko SG
Int J Mol Med; 2018 Jan; 41(1):373-380. PubMed ID: 29115450
[TBL] [Abstract][Full Text] [Related]
7. microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1.
Wang J; Wang X; Liu F; Fu Y
Pharmazie; 2017 Aug; 72(8):475-481. PubMed ID: 29441907
[TBL] [Abstract][Full Text] [Related]
8. Jatrorrhizine inhibits colorectal carcinoma proliferation and metastasis through Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
Wang P; Gao XY; Yang SQ; Sun ZX; Dian LL; Qasim M; Phyo AT; Liang ZS; Sun YF
Drug Des Devel Ther; 2019; 13():2235-2247. PubMed ID: 31371920
[TBL] [Abstract][Full Text] [Related]
9. The plant alkaloid tetrandrine inhibits metastasis via autophagy-dependent Wnt/β-catenin and metastatic tumor antigen 1 signaling in human liver cancer cells.
Zhang Z; Liu T; Yu M; Li K; Li W
J Exp Clin Cancer Res; 2018 Jan; 37(1):7. PubMed ID: 29334999
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer.
Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH
World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394
[TBL] [Abstract][Full Text] [Related]
11. Ponicidin inhibits pro-inflammatory cytokine TNF-α-induced epithelial-mesenchymal transition and metastasis of colorectal cancer cells via suppressing the AKT/GSK-3β/Snail pathway.
Zhang Z; Xu J; Liu B; Chen F; Li J; Liu Y; Zhu J; Shen C
Inflammopharmacology; 2019 Jun; 27(3):627-638. PubMed ID: 30244296
[TBL] [Abstract][Full Text] [Related]
12. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.
Xin H; Wang C; Liu Z
BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631
[TBL] [Abstract][Full Text] [Related]
13. The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer(CRC).
Wang Y; Wu Z; Hu L
Eur J Pharmacol; 2018 Sep; 834():45-53. PubMed ID: 30017802
[TBL] [Abstract][Full Text] [Related]
14. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
[TBL] [Abstract][Full Text] [Related]
15. CircLMNB1 promotes colorectal cancer by regulating cell proliferation, apoptosis and epithelial-mesenchymal transition.
He C; Huang C; Zhou R; Yu H
Onco Targets Ther; 2019; 12():6349-6359. PubMed ID: 31496737
[TBL] [Abstract][Full Text] [Related]
16. BDE-99 (2,2',4,4',5-pentabromodiphenyl ether) triggers epithelial-mesenchymal transition in colorectal cancer cells via PI3K/Akt/Snail signaling pathway.
Wang F; Ruan XJ; Zhang HY
Tumori; 2015; 101(2):238-45. PubMed ID: 25908029
[TBL] [Abstract][Full Text] [Related]
17. miR-497 suppresses epithelial-mesenchymal transition and metastasis in colorectal cancer cells by targeting fos-related antigen-1.
Zhang N; Shen Q; Zhang P
Onco Targets Ther; 2016; 9():6597-6604. PubMed ID: 27822064
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells.
Karimi Dermani F; Saidijam M; Amini R; Mahdavinezhad A; Heydari K; Najafi R
J Cell Biochem; 2017 Jun; 118(6):1547-1555. PubMed ID: 27918105
[TBL] [Abstract][Full Text] [Related]
19. LINC00586 Represses ASXL1 Expression Thus Inducing Epithelial-To-Mesenchymal Transition of Colorectal Cancer Cells Through LSD1-Mediated H3K4me2 Demethylation.
Liu F; Ma X; Bian X; Zhang C; Liu X; Liu Q
Front Pharmacol; 2022; 13():887822. PubMed ID: 35586041
[TBL] [Abstract][Full Text] [Related]
20. ARID1A regulates E-cadherin expression in colorectal cancer cells: a promising candidate therapeutic target.
Erfani M; Zamani M; Hosseini SY; Mostafavi-Pour Z; Shafiee SM; Saeidnia M; Mokarram P
Mol Biol Rep; 2021 Oct; 48(10):6749-6756. PubMed ID: 34424445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
